Home > SWOT Analysis > Chelsea Therapeutics (CHTP) SWOT Analysis





Chelsea Therapeutics (CHTP) SWOT Analysis Profile

Chelsea Therapeutics International, Ltd., founded in 2002, acquires and develops pharmaceutical products. In the development stage, the companys technologies focus on the treatment of rheumatoid arthritis, psoriasis, cancer, immunological disorders, neurogenic orthostatic hypotension, and other autonomic disorders. Chelsea Therapeutics is headquartered in Charlotte, North Carolina. (read full profile)

Additional Information

What is a SWOT Analysis? It is a way of evaluating the strengths, weaknesses, opportunities, and threats that affect something. See WikiWealth's SWOT tutorial for help. Remember, vote up the most important comments. Check out WikiWealth's entire database of free SWOT reports or use our SWOT analysis generator to create your own SWOT template.

Receive News & Ratings Via Email

Free Email Newsletter

SWOT Conclusion

Strengths + Opportunities = 0

Threats + Weaknesses = 1

… A history of overcoming weaknesses makes it difficult for other firms to exploit their difficulties.